Critical roles of specimen type and temperature before and during fixation in the detection of phosphoproteins in breast cancer tissues

[1]  G. Mills,et al.  Influence of Biospecimen Variables on Proteomic Biomarkers in Breast Cancer , 2014, Clinical Cancer Research.

[2]  Jingchun Zhu,et al.  Realizing the Promise of Reverse Phase Protein Arrays for Clinical, Translational, and Basic Research: A Workshop Report , 2014, Molecular & Cellular Proteomics.

[3]  Rajesh C. Dash,et al.  A call to standardize preanalytic data elements for biospecimens. , 2014, Archives of pathology & laboratory medicine.

[4]  Y. Kluger,et al.  A Tissue Quality Index – an Intrinsic Control for Measurement of Effects of Pre-analytical Variables on FFPE Tissue , 2014, Laboratory Investigation.

[5]  J. Bordeaux,et al.  Comparison of HER2 and Phospho-HER2 Expression between Biopsy and Resected Breast Cancer Specimens Using a Quantitative Assessment Method , 2013, PloS one.

[6]  M. Dowsett,et al.  Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  A. Sapino,et al.  A Collection of Primary Tissue Cultures of Tumors from Vacuum Packed and Cooled Surgical Specimens: A Feasibility Study , 2013, PloS one.

[8]  Christoph Schaab,et al.  Delayed times to tissue fixation result in unpredictable global phosphoproteome changes. , 2013, Journal of proteome research.

[9]  A. Sapino,et al.  Current Challenges for HER2 Testing in Diagnostic Pathology: State of the Art and Controversial Issues , 2013, Front. Oncol..

[10]  David R. Chafin,et al.  Rapid Two-Temperature Formalin Fixation , 2013, PloS one.

[11]  Tyler T. Risom,et al.  Targeting Activated Akt with GDC-0068, a Novel Selective Akt Inhibitor That Is Efficacious in Multiple Tumor Models , 2013, Clinical Cancer Research.

[12]  Yuval Kluger,et al.  Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues. , 2012, Journal of the National Cancer Institute.

[13]  Kurt Zatloukal,et al.  Variability of protein and phosphoprotein levels in clinical tissue specimens during the preanalytical phase. , 2012, Journal of proteome research.

[14]  Friedrich Feuerhake,et al.  Effects of cold ischemia and inflammatory tumor microenvironment on detection of PI3K/AKT and MAPK pathway activation patterns in clinical cancer samples , 2012, International journal of cancer.

[15]  A. Sapino,et al.  Critical steps in tissue processing in histopathology. , 2012, Recent patents on DNA & gene sequences.

[16]  L. True,et al.  Impact of Preanalytic Factors on the Design and Application of Integral Biomarkers for Directing Patient Therapy , 2012, Clinical Cancer Research.

[17]  S. Rodenhuis,et al.  Neoadjuvant chemotherapy in ER+ HER2− breast cancer: response prediction based on immunohistochemical and molecular characteristics , 2012, Breast Cancer Research and Treatment.

[18]  A. Sapino,et al.  The pathologic complete response open question in primary therapy. , 2011, Journal of the National Cancer Institute. Monographs.

[19]  E. Petricoin,et al.  One-Step Preservation of Phosphoproteins and Tissue Morphology at Room Temperature for Diagnostic and Research Specimens , 2011, PloS one.

[20]  M. Dowsett,et al.  Relationship between estrogen receptor, progesterone receptor, HER-2 and Ki67 expression and efficacy of aromatase inhibitors in advanced breast cancer. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  R. Langer,et al.  Protein Microarray-based Comparison of HER2, Estrogen Receptor, and Progesterone Receptor Status in Core Biopsies and Surgical Specimens From FFPE Breast Cancer Tissues , 2011, Applied immunohistochemistry & molecular morphology : AIMM.

[22]  A. Sapino,et al.  Formalin Fixation at Low Temperature Better Preserves Nucleic Acid Integrity , 2011, PloS one.

[23]  K. Becker,et al.  Correction: Successful Protein Extraction from Over-Fixed and Long-Term Stored Formalin-Fixed Tissues , 2011, PLoS ONE.

[24]  H. Park,et al.  Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen , 2011, Journal of Cancer Research and Clinical Oncology.

[25]  Y. Tamaki,et al.  Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[26]  K. Becker,et al.  “Liquid Morphology”: Immunochemical Analysis of Proteins Extracted From Formalin-fixed Paraffin-embedded Tissues Combining Proteomics With Immunohistochemistry , 2011, Applied immunohistochemistry & molecular morphology : AIMM.

[27]  Funda Meric-Bernstam,et al.  Deciphering the role of PI3K/Akt/mTOR pathway in breast cancer biology and pathogenesis. , 2010, Clinical breast cancer.

[28]  A. Sapino,et al.  Chemotherapy with or without trastuzumab. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  M. Dowsett,et al.  Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer , 2010, Breast Cancer Research.

[30]  Gianni Bussolati,et al.  Vacuum-based preservation of surgical specimens: an environmentally-safe step towards a formalin-free hospital. , 2010, The Science of the total environment.

[31]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. , 2010, Archives of pathology & laboratory medicine.

[32]  Federica Cavallo,et al.  Attenuation of PI3K/Akt-Mediated Tumorigenic Signals through PTEN Activation by DNA Vaccine-Induced Anti-ErbB2 Antibodies , 2010, The Journal of Immunology.

[33]  H. Juhl.  Preanalytical aspects: A neglected issue , 2010, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[34]  L. De Cecco,et al.  Impact of biospecimens handling on biomarker research in breast cancer , 2009, BMC Cancer.

[35]  Thomas Burke,et al.  Human Biospecimen Research: Experimental Protocol and Quality Control Tools , 2009, Cancer Epidemiology Biomarkers & Prevention.

[36]  R. Buesa.  Histology without formalin? , 2008, Annals of diagnostic pathology.

[37]  G. Forni,et al.  ErbB2 transgenic mice: a tool for investigation of the immune prevention and treatment of mammary carcinomas. , 2008, Current protocols in immunology.

[38]  Gianni Bussolati,et al.  Tissue transfer to pathology labs: under vacuum is the safe alternative to formalin , 2008, Virchows Archiv.

[39]  C. Fenoglio-Preiser,et al.  Stability of Phosphoprotein as a Biological Marker of Tumor Signaling , 2005, Clinical Cancer Research.

[40]  Jeffrey E. Green,et al.  The promise of genetically engineered mice for cancer prevention studies , 2005, Nature Reviews Cancer.

[41]  H. Juhl,et al.  Tissue ischemia time affects gene and protein expression patterns within minutes following surgical tumor excision. , 2004, BioTechniques.

[42]  Piero Musiani,et al.  Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions. , 2004, The Journal of clinical investigation.

[43]  Piero Musiani,et al.  Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice , 1998, The Journal of experimental medicine.

[44]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). , 2010, Archives of pathology & laboratory medicine.

[45]  Daniela Berg,et al.  Molecular profiling of signalling pathways in formalin-fixed and paraffin-embedded cancer tissues. , 2010, European journal of cancer.

[46]  M. Dowsett.  Preoperative models to evaluate endocrine strategies for breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.